InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Wentworth Kory James, 首席财务官. Officer active across 1 company, notably Entrada Therapeutics, Inc.. Cumulatively, 33 disclosures have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €378k. Activity tracked since 1 March 2022. The latest transaction was filed on 2 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Wentworth Kory James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报33 总计
1,733 股@ US$7.14390.0046% mcap1.9% 占其流量Common StockSEC:0001725663-26-000007:0
2,500 股@ US$12.950.011% mcap50.0% 占其流量Common StockSEC:0001725663-26-000005:0
5,089 股@ US$13.001110.7% 占其流量Common StockSEC:0001725663-26-000003:0
7,988 股@ US$12.254915.7% 占其流量Common StockSEC:0001725663-26-000002:0
44,600 股0Common StockSEC:0001725663-26-000001:0
8,910 股@ US$9.981119.4% 占其流量Common StockSEC:0001725663-25-000004:0
1,734 股@ US$5.43022.5% 占其流量Common StockSEC:0001725663-25-000003:0
11,134 股@ US$2.106.2% 占其流量Common StockSEC:0001689375-25-000019:0
1,784 股@ US$10.675.2% 占其流量Common StockSEC:0001689375-25-000016:0
42,400 股0Common StockSEC:0001689375-25-000014:0
1,000 股@ US$2.100.6% 占其流量Common StockSEC:0001689375-24-000068:0
6,000 股@ US$2.103.5% 占其流量Common StockSEC:0001689375-24-000065:0
3,195 股@ US$14.97112.8% 占其流量Common StockSEC:0001689375-24-000055:0
462 股@ US$15.76111.9% 占其流量Common StockSEC:0001689375-24-000049:0
1,758 股@ US$14.957.1% 占其流量Common StockSEC:0001689375-24-000039:0
9,000 股@ US$2.105.1% 占其流量Common StockSEC:0001689375-24-000017:0
4,086 股@ US$12.306713.6% 占其流量Common StockSEC:0001689375-24-000008:0
30,900 股0Common StockSEC:0001689375-24-000005:0
2,200 股@ US$2.101.2% 占其流量Common StockSEC:0001689375-23-000077:0
14,200 股0Common StockSEC:0001689375-23-000064:0
6,116 股@ US$2.103.4% 占其流量Common StockSEC:0001689375-23-000048:0
8,790 股@ US$2.105.0% 占其流量Common StockSEC:0001689375-23-000045:0
17,500 股@ US$2.109.8% 占其流量Common StockSEC:0001689375-23-000044:0
14,200 股0Common StockSEC:0001689375-23-000028:0
28,400 股0Common StockSEC:0001689375-23-000015:0
33 条申报中的 25 条
About Wentworth Kory James
WENTWORTH KORY JAMES is Chief Financial Officer at Entrada Therapeutics, Inc. He has 32 filings in total. Among the sampled recent filings, they cover the period from 2022-03-03 to 2026-04-02, with EUR 0 in buys and EUR 378165 in sells, and the most frequent transaction nature is Option exercise.
